| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Dec―19 |
Association between D-dimers and in-hospital all-cause mortality in COVID-19 patients at a tertiary hospital in South Africa: A retrospective study |
J Matimba, T Ellis, E S Grossman, A Goolam Mahomed |
| 2 |
[GO] |
2025―Mar―31 |
Intensive care unit models in pandemics and beyond: Striking the balance between efficiency, ethics and equity |
U Lalla |
| 3 |
[GO] |
2025―Mar―31 |
An open intensive care unit (ICU) model is a viable option for the acute expansion of ICU capacity in the state sector: A study of a needs-based strategy during the COVID-19 pandemic in a tertiary ICU in South Africa |
E S Gwala, A Ramkillawan, M T D Smith |
| 4 |
[GO] |
2025―Mar―31 |
Pulmonary ultrasound in COVID-19 and non-COVID-19 pneumonia in South Africa. An observational study. |
S A Van Blydenstein, T Nell, C Menezes, B F Jacobson, S Omar |
| 5 |
[GO] |
2024―Dec―12 |
The utility of procalcitonin as a biomarker of hospital-acquired infection in severe COVID-19 |
C Schmidt, P S Nyasulu, I Fwemba, U Lalla, B W Allwood, A Parker, et al. (+6) J J Taljaard, L N Sigwadhi, J L Tamuzi, A E Zemlin, R T Erasmus, C F N Koegelenberg |
| 6 |
[GO] |
2024―Nov―14 |
The impact of mild COVID-19 on medium-term respiratory function |
J Van Heerden, H Strijdom, A Parker, B W Allwood, U Lalla, C J Lombard, C F N Koegelenberg |
| 7 |
[GO] |
2024―Jul―05 |
The impact of the COVID-19 pandemic on lung cancer presentation at a high-volume tertiary referral centre in South Africa |
I Fredericks, E M Irusen, B W Allwood, C F N Koegelenberg |
| 8 |
[GO] |
2024―Apr―05 |
The significance of monitoring respiratory sample cultures and polymerase chain reaction tests for detecting bacterial pathogens in severely and critically ill patients with COVID-19 |
D Strelkova, V Kuleshov, E Burmistrova, I Sychev, Y Savochkina, D Danilov, et al. (+7) S Yatsyshina, E Glushchenko, M Elkina, N Ananicheva, A Yasneva, S Topolyanskaya, S Rachina |
| 9 |
[GO] |
2024―Apr―05 |
High-flow nasal oxygen in resource-constrained, non-intensive, high-care wards for COVID-19 acute hypoxaemic respiratory failure: Comparing outcomes of the first v. third waves at a tertiary centre in South Africa |
G Audley, P Raubenheimer, G Symons, M Mendelson, G Meintjes, N A B Ntusi, et al. (+5) S Wasserman, S Dlamini, K Dheda, R Van Zyl-Smit, G Calligaro |
| 10 |
[GO] |
2023―Sep―26 |
A point-prevalence study of body mass indices in HIV-positive and HIV-negative patients admitted to hospital with COVID-19 in South Africa |
A Parker, A G B Broadhurst, M S Moolla, L Amien, R Ahmed, J J Taljaard, et al. (+3) G Meintjes, P Nyasulu, C F N Koegelenberg |
| 11 |
[GO] |
2023―Aug―07 |
The effect of inhaled nitric oxide on shunt fraction in mechanically ventilated patients with COVID-19 pneumonia |
A G P Van Zyl, B W Allwood, C F N Koegelenberg, U Lalla, F Retief |
| 12 |
[GO] |
2022―Dec―20 |
Role of chest radiograph in predicting the need for ventilator support in COVID-19 patients |
G Patnayak, R Rastogi, L Khajuria, A Mohan, N Jain, R Varshney, et al. (+5) V K Singh, V Patrap, S Pathak, A Jain, K Duggad |
| 13 |
[GO] |
2022―Oct―05 |
The optimal management of the patient with COVID-19 pneumonia: HFNC, NIV/CPAP or mechanical ventilation? |
A G B Broadhurst, C Botha, G Calligaro, C Lee, U Lalla, C F N Koegelenberg, et al. (+4) P D Gopalan, I A Joubert, G A Richards, B W Allwood |
| 14 |
[GO] |
2022―May―08 |
The effectiveness of high-flow nasal cannula and standard non-rebreathing mask for oxygen therapy in moderate category COVID-19 pneumonia: Randomised controlled trial |
A Nazir, A Saxena |
| 15 |
[GO] |
2022―Feb―02 |
New life after near death: Surviving critical COVID-19 infection |
B Hodkinson, P Gina, M Schneider |
| 16 |
[GO] |
2022―Feb―02 |
Hearing the voices of COVID-19 survivors |
E J Shaddock, G A Richards |
| 17 |
[GO] |
2022―Feb―02 |
A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2 |
K Dheda, S Charalambous, A S Kharat, A von Delft, R N van Zyl-SMit, R Perumal, et al. (+24) B W Allwood, A Esmail, M L Wong, A G Duse, G Richards, C Feldman, M Mer, K Nyamande, U Lalla, C F N Koegelenberg, F Venter, H Dawood, S Adams, N A B Ntusi, H-M van der Westhuizen, M-Y S Moosa, N A van der Westhuizen, H Moultrie, J Nel, H Hausler, W Preiser, L Lasersohn, H J Zar, G J Churchyard |
| 18 |
[GO] |
2022―Feb―02 |
Evolution of SARS-CoV-2 mutational variants: Hysteria or hope for the future? |
A Esmail, A J Scott, K Dheda |
| 19 |
[GO] |
2021―Oct―27 |
A position statement and practical guide to the use of particulate filtering facepiece respirators (N95, FFP2, or equivalent) for South African health workers exposed to respiratory pathogens including Mycobacterium tuberculosis and SARS-CoV-2 |
K Dheda, S Charalambous, A S Karat, A Von Delf, U G Lalloo, R Van Zyl Smit, et al. (+25) R Perumal, B W Allwood, A Esmail, M L Wong, A G Duse, G Richards, C Feldman, M Mer, K Nyamande, U Lalla, C F N Koegelenberg, F Venter, H Dawood, S Adams, N A B Ntusi, H-M Van der Westhuizen, M-Y S Moosa, N A Martinson, H Moultrie, J Nel, H Hausler, W Preiser, L Lasersohn, H J Zar, G J Churchyard |
| 20 |
[GO] |
2021―Jun―23 |
Radiological and functional lung sequelae of COVID-19 |
Qu Gurirab |
| 21 |
[GO] |
2021―Jun―23 |
Outcome of hospitalisation for COVID-19 in patients with interstitial lung disease |
A Chacko |
| 22 |
[GO] |
2021―Jun―23 |
Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia |
E M Taban, GR Tintinger, D Joseph, P Gaylard, G Richards |
| 23 |
[GO] |
2021―Jun―23 |
A case of COVID-19 re-infection in Libya |
AA Alzedam, AM Bengblya, MJ Zeglam, ET Benmassoud, SM Bennji |
| 24 |
[GO] |
2020―Sep―17 |
South African Thoracic Society statement on obstructive airways disease and COVID-19 |
R Van Zyl Smit, C Feldman, G Richards, S Abdool-Gaffar, U Lallo, I Kalla, et al. (+2) C F N Koegelenberg, K Dheda |
| 25 |
[GO] |
2020―Sep―17 |
Controversies and challenges with COVID-19 in children: Why are they less susceptible and should they be at home rather than in school? |
R Masekela, A J Wessels |
| 26 |
[GO] |
2020―Sep―17 |
The use of corticosteroids for COVID-19 infection |
G A Richards, C Feldman |
| 27 |
[GO] |
2020―Sep―17 |
Brief review: Cardiac complications and platelet activation in COVID-19 infection |
C Feldman, R Anderson |
| 28 |
[GO] |
2020―May―14 |
Cardiac complications in community-acquired pneumonia and COVID-19 |
C Feldman |
| 29 |
[GO] |
2020―May―14 |
Current evidence for directed and supportive investigational therapies against COVID-19 |
R Van Rensburg, V Pillay-Fuentes Lorente, E H Decloedt |
| 30 |
[GO] |
2020―May―14 |
Diagnosis of COVID-19: Considerations, controversies and challenges |
K Dheda, S Jaumdally, M Davids, J-W Wang, P Gina, A Pooran, et al. (+4) E Makambwa, A Esmail, E Vardas, W Preiser |
| 31 |
[GO] |
2020―May―14 |
Coronavirus disease 2019: Lessons, risks and challenges |
G A Richards, S Stacey |
|
